7 results
8-K
EX-99.3
ZNTL
Zentalis Pharmaceuticals Inc
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
-77) 56.0 (34-75) 61.0 (34-83) Race and Ethnicity, N (%) White 24 (92.3) 34 (94.4) 16 (88.9) 34 (97.1) 108 (93.9) Black or African-American 0 0 0 0 0
8-K
EX-99.2
0cfbhvfo zuylzscp8r
5 Jun 23
Regulation FD Disclosure
2:24pm
- Prev
- 1
- Next